Clinical Significance of Proper IV Catheter Securement

Peripheral intravenous (PIV) catheter securement is not merely a matter of convenience — it directly affects patient safety outcomes including catheter failure rates, phlebitis incidence, and catheter-related bloodstream infection (CRBSI) risk. According to the Infusion Nurses Society (INS) 2021 Infusion Therapy Standards of Practice, PIV catheter failure rates range from 35-50% before intended completion of therapy, with inadequate securement identified as a contributing factor in 18-24% of premature failures. The estimated cost of PIV replacement is $28-35 per catheter (materials + nursing time), with aggregate US healthcare costs exceeding $4 billion annually for unnecessary catheter replacements.

Evidence-Based Securement Methods

Transparent Semi-Permeable Membrane (TSM) Dressing

Design: Polyurethane film dressing with moisture vapor transmission rate (MVTR) >800 g/m²/24h and acrylic or silicone adhesive border. Transparent for insertion site visualization without removal.

Evidence: CDC 2017 Guidelines for Prevention of Intravascular Catheter-Related Infections (Category IA recommendation): Transparent dressings changed every 5-7 days provide equivalent infection risk to gauze dressings changed every 2 days, with advantage of site visualization reducing unnecessary manipulation. A 2019 Cochrane review (22 studies, 7,438 catheters) found no significant difference in CRBSI rates between TSM and gauze dressings (RR 0.98, 95% CI 0.74-1.30).

Application Protocol: Center dressing over insertion site, smooth from center outward avoiding wrinkles (wrinkles create channels for bacterial migration), ensure complete seal around catheter hub. Do not stretch dressing — tension creates shear forces on skin and may cause MARSI upon removal.

Sutured Securement

Design: Nylon or polypropylene suture through catheter wings/hub, tied to skin.

Evidence: Historically the "gold standard" for central venous catheters, now largely replaced by sutureless securement devices (SSDs). Sutures create needle-stick injury risk (estimated 2-3% per catheter placement), skin puncture sites as portals for infection, and require removal at catheter exchange/removal. INS 2021 Standards recommend SSDs over sutures for central lines.

Current Role: Limited to specific applications where SSDs are contraindicated or unavailable. Should not be used for routine PIV securement.

Sutureless Securement Devices (SSD)

Design: Adhesive anchor devices that grip the catheter hub without penetrating skin. Multiple designs: adhesive anchors with integrated catheter clips, subcutaneous anchoring systems (for longer-term catheters), integrated securement dressings combining TSM with catheter stabilization.

Evidence: A 2020 systematic review in Journal of Infusion Nursing (14 studies, 3,212 catheters) found SSDs reduced catheter dislodgement by 45% (RR 0.55, 95% CI 0.41-0.74) and CRBSI by 40% (RR 0.60, 95% CI 0.41-0.88) compared to suture-only securement. INS and CDC guidelines now recommend SSDs as first-line securement for all vascular access devices.

Tissue Adhesive (Cyanoacrylate)

Design: Medical-grade cyanoacrylate (n-butyl or octyl) applied as liquid to catheter-skin junction, polymerizing on contact with moisture to form strong flexible bond.

Evidence: Emerging evidence from RCTs shows cyanoacrylate reduces catheter failure by 25-30% and phlebitis by 15-20% compared to standard dressing alone. Mechanism includes: enhanced mechanical fixation, antimicrobial barrier effect, and sealing of catheter-skin junction to prevent bacterial migration. INS 2021 conditionally recommends cyanoacrylate as adjunctive securement.

Comprehensive Securement Protocol

1. Skin Preparation: Cleanse site with >0.5% chlorhexidine in 70% alcohol (2% CHG preferred), allow to air dry completely (minimum 30 seconds). Skin must be clean, dry, and free of hair.
2. Primary Dressing: Apply sterile TSM dressing centered over insertion site, ensuring complete seal. Dressing should extend minimum 2.5 cm beyond insertion site in all directions.
3. Secondary Securement: Apply SSD or sterile tape to catheter hub and extension tubing, creating a strain-relief loop. Tape should not cover the insertion site (maintains visibility).
4. Documentation: Label dressing with date, time, catheter gauge, and inserter initials. Document in patient record: insertion site, catheter size, securement method, dressing type, and assessment findings.
5. Ongoing Assessment: Inspect site at minimum every 4 hours (ICU), every shift (wards). Assess for: dressing integrity (replace if non-occlusive, soiled, or damp), signs of phlebitis (tenderness, erythema, palpable venous cord), infiltration/extravasation, and catheter function.
6. Dressing Change Interval: TSM dressings every 5-7 days; gauze dressings every 2 days; immediately if loose, soiled, or damp.

Special Populations

Neonates/Pediatrics: Use silicone-based dressings to minimize epidermal stripping. Consider limb splinting to prevent accidental dislodgement. INS neonatal recommendations specify gentle adhesives and frequent assessment due to immature skin barrier.

Elderly/Fragile Skin: Apply skin barrier film before adhesive dressing. Use silicone-based adhesives where available. Minimize dressing changes (extend to 7 days when clinically appropriate). Use adhesive remover for atraumatic dressing removal.

Diaphoretic/Febrile Patients: Consider reinforced dressing with additional border tape. More frequent assessment indicated — moisture reduces adhesive integrity.

Linmed Medical provides a complete portfolio of IV securement products including transparent film dressings, non-woven fixation dressings, PE waterproof dressings, and silicone foam fixation dressings — all CE certified, ISO 13485:2016 compliant, with full biocompatibility testing documentation.